The paper examines potential reforms to current policies and practices related to orphan drug develo...
Read moreAccording to the report, the financing of cancer drugs in Spain is “very high” with 90% of oncol...
Read moreThe UK looks set to become the first country in the world to use a subscription-style payment model ...
Read moreThe amendment includes a number of articles which aims to “streamline the negotiation of the price...
Read moreAccording to the Department of Health and Social Care (DHSC), the commitments will enable patients t...
Read moreConsequently, paybacks from pharmaceutical manufacturers of around €1 billion will be due from pha...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreThe DHSC is proposing to increase the statutory scheme payment percentage for 2022 from 10.9% to 14....
Read moreThe proposals are set out in the draft Statutory Health Insurance Financial Stabilisation Bill which...
Read moreBeyond the regulatory level, a well-recognised challenge for companies launching drugs in orphan dis...
Read more